NEWS & INSIGHTS

Jeremy Schafer, director of Precision’s Payer Access Solutions, shares his thoughts on drug pricing, M&A activity, 340B changes, and other things top-of-mind for 2018. (more…)

Jeremy Schafer, director of Precision’s Payer Access Solutions, offers advice to healthcare executives on helping patients get access to crucial new cancer drugs. (more…)

ADDITION OF NEW YORK-BASED FIRM COMPLEMENTS AND STRATEGICALLY EXPANDS PRECISION’S EXISTING GLOBAL MARKET ACCESS EXPERTISE AND CAPABILITIES

New York, NY – Tuesday, January 30, 2018 – Precision Value & Health today announced it is acquiring Insight Strategy Advisors (ISA), a New York-based leading market access consultancy supporting value demonstration, pricing, reimbursement, and distribution for biopharmaceutical companies. ISA will become part of Precision Xtract, the global market access consultancy within Precision Value & Health.

(more…)

Jeremy Schafer, director of Precision’s Payer Access Solutions, offers insights into combating the risk and exposures of gene therapy. (more…)

Jeremy Schafer, director of Precision’s Payer Access Solutions, weighs in on the concern of payer coverage for Dermira’s olumacostat glasaretil acne topical treatment. (more…)

Jeremy Schafer, director of Precision’s Payer Access Solutions, contributes his perspectives on drug pricing in a PharmaVOICE feature article. (more…)

Precision Xtract is proud to be named one of the year’s most innovative developments by industry insider PM360. (more…)

A new Precision Health Economics-authored study on the societal value of CAR-T therapy is generating a significant level of interest within the scientific community. (more…)

MM&M editor-in-chief Marc Iskowitz quotes Precision’s Maureen Hennessey and cites new findings from Precision for Value’s Rapid Pulse survey in an article examining Otsuka’s new “digital drug” and the continued importance of adherence. (more…)

Precision for Value’s Jeremy Schafer discusses the impact of new and proposed state legislation on drug pricing with MedCity News. According to Schafer, new policies could present challenges for manufacturers in evolving their pricing strategies.  (more…)